Abalone Bio YC 申请

Winter 2020Active

Abalone Bio 在 Winter 2020 批次的 Y Combinator 中作为一家 Healthcare 公司进行过。以下是：公司做什么、谁创立了它，以及其 YC 申请，按照真实 YC 表格逐题重建。

YC 批次: Winter 2020
行业: HealthcareDrug Discovery and Delivery
团队规模: 14
状态: Active
已发布: 2020

创始人

Richard YuFounder
Gustavo PesceFounder

Abalone Bio 做什么

Abalone Bio is tackling challenging undrugged targets underlying diseases affecting millions, focusing first cell-specific antibody drugs to treat obesity and metabolic disease without the GI side effects that cause 25% of GLP-1 drug patients to quit after 1 year. + High throughput experimental measurement uniquely leverages AI/ML: We’ve engineered cells to measure antibodies for pharmacological activity, not just structure or binding like others, 100 million at a time, 100X+ the throughput of others. With our large, proprietary activity datasets, we uniquely leverage ML to both unlock the discovery of rare hits and generate optimized hits for challenging targets, starting with G-protein coupled receptors (GPCRs) + Proven success: We have developed antibody agonists (activators) for 2 out of the 8 G-protein coupled receptors ever drugged by biotech. + Pharma traction: We’ve secured 3 partnerships with $3M in revenue and $125M in downstream value. + Externally validated science: We’ve been awarded $7M in non-dilutive grant funding for platform and program development.

Abalone Bio 的 YC 申请，重建版

Y Combinator 申请

Abalone Bio，Winter 2020 期。来自公开数据的真实申请问题解答。

Founders2
Company7
Progress7
Idea4
Equity3
Curious2
Batch Preference1

Company

Company name

Abalone Bio

Describe what your company does in 50 characters or less.

We create activating antibodies to treat diseases others can't.

What is your company going to make? Please describe your product and what it does or will do.

We build a platform that combines high-throughput experimental antibody screening with machine learning to discover activating antibodies targeting cell-specific receptors. Our product enables discovery and optimization of rare antibody hits against challenging targets like GPCRs, starting in obesity and metabolic diseases, focusing on safety and efficacy beyond current drugs.

Where do you live now, and where would the company be based after YC?

We live in San Francisco, CA, and the company is based here.

Explain your decision regarding location.

San Francisco is a hub for biotech and AI talent, which is critical for our platform combining synthetic biology and machine learning. Being in SF keeps us close to partners and investors focused on healthcare innovation.

21 更多回答在完整申请中

Founders, Progress, Idea, Equity, Curious, Batch Preference 包含在完整版中。创建免费账户即可在 YC Insights 中打开，紧邻每个其他 YC 批次。

查看完整申请

常见问题解答

这是 Abalone Bio 的真实 YC 申请吗？

不是。Y Combinator 对提交的申请保密。这是重建版：使用 Abalone Bio 的公开数据（发布笔记、创始人背景、产品描述）回答真实的 YC 表格问题。它展示了像 Abalone Bio 这样的公司会如何向 YC 自我介绍，而不是他们提交的文本。

Abalone Bio 是哪个 YC 批次的？

Abalone Bio 是 Y Combinator Winter 2020 批次的成员。

谁创立了 Abalone Bio？

Abalone Bio 由 Richard Yu, Gustavo Pesce 创立。

Abalone Bio 做什么？

We create activating antibodies to treat diseases others can’t.

如何阅读完整的重建申请？

创建免费的 Round Funded 账户。YC Insights 中包含 Abalone Bio 的完整 26 个问题的版本，以及其他所有 YC 批次的公司信息。